Kevin Chinn

Kevin Chinn is an accomplished healthcare executive with extensive experience in business development and go-to-market strategies, particularly in cell and gene therapies. Currently serving as the Vice President of Business Development for Cell & Gene Therapy at AmerisourceBergen since November 2022, Kevin focuses on enhancing value for innovators throughout the commercialization journey. Prior to this role, Kevin held multiple leadership positions at CVS Health from August 2014 to November 2022, including Division Head of Health System Alliances and Division Head of Sales & Business Development, where responsibilities encompassed fostering sustainable relationships with health systems. Kevin's career began in sales positions at St. Jude Medical, Medtronic, and ACMI. Kevin holds a Bachelor of Science degree in Business Administration and Business Economics from the University of Arizona's Eller College of Management.